Rohde & Schwarz and LITEON will collaborate to showcase a production-optimized test setup for high-throughput multi-device ...
UConn Health told legislators that the state stands to lose $60 million in federal funds if the measure doesn’t go through.
Since the emergence of COVID-19 in late 2019, the gold standard in testing for the disease has been a nuclear-derived technique: real-time reverse transcription–polymerase chain reaction, or real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results